Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma

BACKGROUND: This phase II study was designed to evaluate the activity and safety of a combination of epirubicin, oxaliplatin and docetaxel in metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. METHODS: Forty patients with measurable distant metastases received epirubicin 50 mg/m(2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Di Lauro, Luigi, Giacinti, Laura, Arena, Maria Grazia, Sergi, Domenico, Fattoruso, Silvia Ileana, Giannarelli, Diana, Lopez, Massimo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2009
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2657908/
https://ncbi.nlm.nih.gov/pubmed/19267943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-28-34
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados